Mukka Proteins Share Price Surges 8% on New Domestic and International Orders

Mukka Proteins share price jumped over 8% on March 6, 2025, after securing multiple new supply orders. These deals have strengthened its market position, pushing its total order book to around ₹200 crore.

New Supply Agreements

The company has signed a ₹31.77 crore supply deal with Avanti Feeds for fish meal and fish oil in the domestic market. It also secured an international order worth $2,20,000 (₹1.91 crore) from Bangladesh-based Padma Feed & Chicks. Additionally, its subsidiary, Mukka Proteins Vietnam, placed an order for fish meal worth $10,00,000 (₹8.7 crore). These orders will be fulfilled immediately, highlighting the company’s efficiency in meeting rising demand.

Mukka Proteins stated that these deals reinforce its strong position in the global marine protein sector and its commitment to high-quality, sustainable products.

Q3 FY25 Financial Performance

In Q3 FY25, Mukka Proteins’ net profit surged 151% YoY to ₹25 crore, driven by cost efficiencies. However, revenue declined 40% YoY to ₹280 crore from ₹468 crore. On a sequential basis, revenue recovered strongly, rising 130% to ₹122 crore compared to the previous quarter. The profit margin also improved from 2% to 8.5% YoY.

CEO K Mohammed Haris attributed the company’s performance to cost-effective production and a diverse customer base. He noted that despite challenges like higher fishing limits in Peru affecting pricing, Mukka Proteins has maintained profitability through efficiency and strategic planning.

Future Growth Plans

As India’s largest fish meal and fish oil producer, Mukka Proteins aims to expand its production capacity, diversify its product range, and enter new global markets. The company is focused on strengthening its role in global food security through sustainable and scalable operations.

Market Trends and Stock Outlook

Following the new order announcements, Mukka Proteins’ stock hit an intra-day high of ₹35.80, though it remains 36% below its 52-week high of ₹56.52 from July 2024.

The stock had dropped 6.6% in February and 11.2% in January but remains 28% above its IPO issue price of ₹28. With a strong order pipeline and strategic expansion, Mukka Proteins is well-positioned for long-term growth.

Conclusion

With a growing order book, rising profitability, and strategic expansion, Mukka Proteins is strengthening its global presence. The company remains well-positioned for sustained growth.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.